Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Emisphere Technologies, Inc.
🇺🇸
United States
Country
🇺🇸
United States
Ownership
Public, Subsidiary
Established
1986-01-01
Employees
51
Market Cap
-
Website
http://www.emisphere.com
Clinical Trials
Related News
Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin
Not Applicable
Completed
Conditions
Vitamin B 12 Deficiency
Interventions
Other: Vitamin B12 (cyanocobalamin)
Subscribe
First Posted Date
2011-03-11
Last Posted Date
2011-03-11
Lead Sponsor
Emisphere Technologies, Inc.
Target Recruit Count
49
Registration Number
NCT01312831
Subscribe
Oral Cyanocobalamin (Eligen B12) Bioavailability Study
Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Cyanocobalamin
Subscribe
First Posted Date
2011-03-09
Last Posted Date
2011-03-09
Lead Sponsor
Emisphere Technologies, Inc.
Target Recruit Count
20
Registration Number
NCT01311739
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy